Perspective Therapeutics, Inc.
CATX
$3.46
-$0.22-5.98%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -47.97% | -62.79% | -46.02% | -- |
| Total Depreciation and Amortization | -- | 105.62% | 5,526.92% | 140.65% | -- |
| Total Amortization of Deferred Charges | -- | -- | 0.00% | -- | -- |
| Total Other Non-Cash Items | -- | 227.89% | 84.22% | 134.72% | -- |
| Change in Net Operating Assets | -- | -121.20% | -557.48% | 2,588.89% | -- |
| Cash from Operations | -124.14% | -255.85% | -195.36% | 133.29% | -10.28% |
| Capital Expenditure | -- | 48.68% | -16,320.22% | -12,989.43% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 97.62% | -- | -- | -- |
| Cash from Investing | 229.41% | 88.23% | -155,632.58% | -13,000.00% | -475.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -8.33% | 0.00% | 23.81% | -- |
| Issuance of Common Stock | -- | -94.00% | -- | 2,827.27% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.89% | -94.00% | -1.99% | 62,700.00% | 23,744.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.16% | -112.92% | -1,785.23% | -149.06% | 1,451.13% |